✦ LIBER ✦

New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease

✍ Scribed by Jacob J. Lokich; Emil Frei III; Norman Jaffe; James Tullis

Publisher: John Wiley and Sons
Year: 1976
Tongue: English
Weight: 421 KB
Volume: 38
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197608)38:2<667::aid-cncr2820380207>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide in combination as first-line c

Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A cancer and leukemia group B study

✍ Jeffrey J. Kirshner; James R. Anderson; Barbara Parker; Maurice Barcos; M. Rober 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 1 views

Background. In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease. Thirty-six evaluable patients were treated with two or three courses of methotrexate, vincristine, prednisone, leucovorin, etoposide, and cyclophos

Testicular dysfunction after cyclophosph

Testicular dysfunction after cyclophosphamide-vincristine-procarbazine-prednisolone chemotherapy for advanced hodgkin's disease a long-term follow-up study

✍ B. S. Charak; Rahul Gupta; Pranoti Mandrekar; Nandini A. Sheth; Shripad D. Banav 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 2 views

Gonadal functions were evaluated in 92 male patients after treatment for advanced Hodgkin's disease. The patients received six to ten cycles of cyclophosphamide, vincristine, procarbazine, and prednisolone (COPP) chemotherapy. All patients were in remission and were followed for 1 to 17 years (media

Successful treatment with chemotherapy a

Successful treatment with chemotherapy and subsequent allogeneic bone marrow transplantation for myeloid blastic crisis of chronic myelogenous leukemia following advanced Hodgkin's disease

✍ Cornelis J. A. Punt; Maja Rozenberg-Arska; Leo F. Verdonck 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 2 views